These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6269658)

  • 21. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
    Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
    Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Beavo JA
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):487-96. PubMed ID: 2831258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
    Naskalski JW; Uciński WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
    Yamakado T; Tanaka F; Hidaka H
    Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Lerea KM; Beavo JA
    J Biol Chem; 1988 Jul; 263(21):10353-8. PubMed ID: 2839485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylethanolamine methyltransferase and cAMP, cGMP phosphodiesterases in lymphocytes and monocytes in sarcoidosis.
    Pacheco Y; Dubois M; Prigent AF; Fonlupt P; Timouyasse L; Rey C; Chambe MT; Biot N; Perrin-Fayolle M; Pacheco H
    Clin Chim Acta; 1987 Mar; 163(3):267-77. PubMed ID: 3034451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three new potential cAMP affinity labels. Inactivation of human platelet low Km cAMP phosphodiesterase by 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphate.
    Grant PG; DeCamp DL; Bailey JM; Colman RW; Colman RF
    Biochemistry; 1990 Jan; 29(4):887-94. PubMed ID: 2160272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
    Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification of cAMP phosphodiesterase from platelets.
    Grant PG; Colman RW
    Methods Enzymol; 1988; 159():772-7. PubMed ID: 2842641
    [No Abstract]   [Full Text] [Related]  

  • 36. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet cGMP-binding phosphodiesterase.
    Hamet P; Tremblay J
    Methods Enzymol; 1988; 159():710-22. PubMed ID: 2842632
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclic nucleotide phosphodiesterase activity in human peripheral blood lymphocytes and monocytes.
    Wedner HJ; Chan BY; Parker CS; Parker CW
    J Immunol; 1979 Aug; 123(2):725-32. PubMed ID: 222843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
    Miot F; Erneux C
    Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.